Table 1.
Extent of the Pulmonary Inflammatory Process of TCR-transgenic Mice Infected with Influenza A Virus
Mice | Virus | Time after infection | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Day 2 | Day 5 | Day 8 | Day 15 | Day 20 | ||||||||
F5–RAG-1−/− | A/NT/60/68, 107 PFU | + | ++ | ++ | * | |||||||
A/NT/60/68, 102 PFU | − | + | + | ± | ± | |||||||
X31, 107 PFU | + | ++ | ++ | * | ||||||||
RAG-1−/− | A/NT/60/68, 107 PFU | ± | + | ++ | ++ | ++ | ||||||
X31, 107 PFU | + | ++ | ++ | * |
++, Intensive pathology with cell inflammation encompassing several segments of lung tissues. Development of extensive lung edema and congestion. Thickened intraalveolar septa and loss of alveoli. +, Inflammatory reaction consisting of a few foci of peribronchiolar and perivascular infiltrates on medium and small airways. There was modest evidence of epithelial necrosis of affected tracheobronchiolar mucosa. ±, Lung tissue with a few infiltrates. No epithelial necrosis or desquamation. −, Lung tissue well aerated. No infiltrates or pathologic alteration of lung tissue.
, At the indicated time, all mice had died.